Site Members can sign up for company wide alerts
Lawsuit Overview
An investor, who currently holds shares of Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), filed a lawsuit against the takeover of Keryx Biopharmaceuticals, Inc. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ: KERX stockholders by agreeing to sell Keryx Biopharmaceuticals, Inc. cheaply via an unfair process. On Jun. 28, 2018, Akebia Therapeut...
You must register (for free) or login to view the entire case.